AI assistant
Sending…
Anterix Inc. — Director's Dealing 2021
Jan 15, 2021
33018_dirs_2021-01-14_a467a0e7-4a79-45c5-a07c-7e683dc0c1fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2021-01-07
Reporting Person: Ashe Gena L (General Counsel & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-07 | Common Stock | A | 849 | $0.00 | Acquired | 20555 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-07 | Stock Option (Right to Buy) | $0.00 | A | 0 | Acquired | 2031-01-07 | Common Stock (0) | Direct |
Footnotes
F1: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest in 2 equal annual installments on January 7, 2022 and January 7, 2023.
F2: The stock option previously reported for 849 shares granted on January 7, 2021 was reported in error. The award received by the reporting person was an award for RSUs as now reported on Table I and not a stock option award as previously reported.
More from Anterix Inc.
Fund Information / Factsheet
2026
Apr 21
Regulatory Filings
2026
Apr 21
Capital/Financing Update
2026
Apr 6
Regulatory Filings
2026
Apr 1
Earnings Release
2026
Feb 11
Interim / Quarterly Report
2026
Feb 11
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30
Board/Management Information
2026
Jan 7
Director's Dealing
2025
Dec 19